Africa & Middle East
When we know what we’re treating, we can proactively channel medicine and strengthen local health care systems. Our efforts include:
- Adding new countries to our Solidarity Fund, a restricted fund for under-resourced settings without access to molecular diagnostic systems and test kits.
- Partnering with patient associations to identify diagnostic needs for patients across Africa.
In 2019, we delivered the first shipment of lifesaving medicine to CML patients in Mozambique. Today, we know of specific patients who are in critical need of a basic diagnostic test—without it, they cannot begin lifesaving treatment.
— Dr. Fatma Dieng Bousso, Senegal
We successfully import cancer treatments into Asia Pacific by partnering with governments, health care practitioners, and patient associations. Our efforts include:
- Aiding individual patients and their families to overcome last mile logistics.
- Hosting regular workshops and support group meetings for patients in Malaysia, Philippines and Thailand.
The Max Schooling Project (Projek Sambung Sekolah), based in Malaysia, offers financial assistance to cancer patients’ children so they can continue their schooling and education. Through this project, we help patients stay on track with their treatment plan while their children have increased access to education. Currently, we have supported more than 100 children in Max Schooling, and the program continues to expand.
— Dr Tee Chuan Ong, Malaysia
Eastern Europe & Central Asia
Since we first opened access to treatment in Eastern Europe & Central Asia, hundreds of CML patients are now living beyond their initial diagnosis. Our efforts include:
- Bridging critical access to diagnostic systems and test kits to our partner institutions whose patients cannot afford to travel out of the country for a blood test.
- Supporting partnering physicians by connecting them with disease experts who can virtually advise on cases, which translates into better patient care.
In 2019, we donated a PCR diagnostic machine to Armenia. Our partner physician, Dr. Karen Meliksetyan has since been able to monitor more than 300 CML patients and prescribe additional lines of treatment. “In some patients, we discovered the treatment failed, or confirmed deep molecular remission and continued the same treatment. It’s very hard for CML patients.”
— Mariam Izoria, (second from right) Program Coordinator, with the Armenian medical team
Outside of accessing treatment, the largest barrier patients face in their journey with cancer is understanding their disease and gaining emotional support. Our efforts include:
- Guiding patients and their families throughout their treatment life cycle through disease education and support.
- Empowering patients by partnering with local patient associations, cancer advocates, and health care professionals.
In September 2019, 11 patients in Guatemala gained access to hope when a second-line treatment for CML was approved for importation by the country’s Ministry of Health. This achievement was made possible through our team and partner physicians’ relentless efforts and commitment to patients.
— Fiorella, mother and cancer patient from Perú, on treatment since 2014
Our team in South Asia organizes critical patient support group meetings for thousands of patients each year. Our efforts include:
- Providing pathways for emotional and community support for patients facing cultural stigmatization.
- Hosting fundraisers and awareness campaigns through our Chai for Cancer.
We partner with Friends of Max, one of the largest patient associations in the world supporting CML and GIST patients in India to connect with thousands of patients yearly. We provide a safe space for patients and their care givers to connect with patients and physicians and help overcome cancer stigma.
— Dr. Manju Sengar, Professor at Tata Memorial Centre, Mumbai
Help bridge access to treatment for more cancer patients around the world.
Become a sponsor to expand humanitarian access to treatment.